KOURION

Serial Number 76172250
602

Registration Progress

Application Filed
Nov 28, 2000
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: KOURION
Previous Owner: Wernet, Peter
Classes: 001, 005

Trademark Image

KOURION

Basic Information

Serial Number
76172250
Filing Date
November 28, 2000
Abandonment Date
June 7, 2007
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 7, 2007
Classes
001 005

Rights Holder

Wernet, Peter

01
Address
Moorenstr. 5
Dusseldorf
DE

Ownership History

Wernet, Peter

Original Applicant
01
Dusseldorf DE

Legal Representation

Attorney
Patricia A Walker

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

36 events
Date Code Type Description Documents
Jul 9, 2007 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jul 7, 2007 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 7, 2006 CNSI S INQUIRY AS TO SUSPENSION MAILED Loading...
Dec 6, 2006 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jun 5, 2006 CNSL S LETTER OF SUSPENSION MAILED Loading...
Jun 3, 2006 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 9, 2006 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Feb 8, 2006 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
May 5, 2006 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 11, 2006 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 11, 2006 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 8, 2006 MAIL I PAPER RECEIVED Loading...
Jan 9, 2006 CNSI S INQUIRY AS TO SUSPENSION MAILED Loading...
Jan 7, 2006 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jun 24, 2005 CNSL S LETTER OF SUSPENSION MAILED Loading...
Jun 23, 2005 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 23, 2005 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 6, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 6, 2005 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 13, 2004 CNSI S INQUIRY AS TO SUSPENSION MAILED Loading...
Dec 11, 2004 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Dec 11, 2004 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
May 24, 2004 CNSL S LETTER OF SUSPENSION MAILED Loading...
May 8, 2004 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 8, 2004 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 12, 2003 CNSI S INQUIRY AS TO SUSPENSION MAILED Loading...
Oct 21, 2003 CFIT O CASE FILE IN TICRS Loading...
Apr 10, 2003 CNSL S LETTER OF SUSPENSION MAILED Loading...
Feb 7, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2003 MAIL I PAPER RECEIVED Loading...
Oct 28, 2002 CNSI S INQUIRY AS TO SUSPENSION MAILED Loading...
Oct 15, 2002 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 23, 2002 CNSL S LETTER OF SUSPENSION MAILED Loading...
Oct 19, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 20, 2001 CNRT F NON-FINAL ACTION MAILED Loading...
Mar 29, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 001
celltherapeutic and stemcell transplant diagnostic preparations for scientific and research; regenerative cell, tissue, and organic preparations for scientific and research use; and clinical testing preparations, namely, preparations from stemcells or differentiated and modified stemcells for scientific and research use
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
pharmaceutical cell preparations as human medicine, namely, for use in the treatment of diseases such as but not limited to degenerative diseases of the liver (eg. cirrhosis), heart (eg. infarct, congestive heart failure), brain and spine (eg. Parkinson's disease, stroke, paralysis, spinal injuries), bone (eg. tumor resections, degenerative bone disease), cartilage (eg. meniscal tears, vertebral discs), pancreas (type I diabetes), vascular disease, degenerative muscle diseases and for hematopoietic reconstitution after cancer treatment; celltherapeutic and stemcell transplant diagnostic preparations for clinical and medical laboratory use; celltherapeutic and stemcell transplant diagnostic reagents; Adjuvant substance for the stemcell therapy; regenerative cell, tissue, and organic preparations for clinical or medical laboratory use; medical reagents, namely, regenerative cell, tissue and organic reagents; stemcells or differentiated and modified stemcell preparations for clinical and medical laboratory use; and medical reagents, namely, stemcells and differentiated and modified stemcell reagents
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001 005